Clearside Biomedical, Inc.CLSDNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank75
3Y CAGR+0.4%
5Y CAGR-6.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+0.4%/yr
vs +4.7%/yr prior
5Y CAGR
-6.8%/yr
Recent acceleration
Acceleration
-4.3pp
Decelerating
Percentile
P75
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $11.81M | -0.5% |
| 2023 | $11.87M | +0.8% |
| 2022 | $11.77M | +0.9% |
| 2021 | $11.66M | +8.5% |
| 2020 | $10.76M | -36.0% |
| 2019 | $16.82M | +14.5% |
| 2018 | $14.68M | +51.4% |
| 2017 | $9.70M | +54.9% |
| 2016 | $6.26M | -4.5% |
| 2015 | $6.55M | - |